Eli Lilly has reduced the prices of certain Zepbound ... Jani Hall is a news editor for Health with a background in health, science, and investigative reporting. Previously, she wrote full time ...

After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer ... Blige’s “Real Love” plays in the background, the cast members, who include a teen boy and several ...

Let's start with the background. Currently there are four branded and patent-protected GLP-1 weight-loss drugs on the market. Novo Nordisk owns two of them: Ozempic and Wegovy. Eli Lilly (NYSE: LLY) ...

The biotech industry may be cooling off, but there’s still plenty to be excited about when it comes to the underlying ...

President Donald Trump’s firing this week of two Democratic members of the Federal Trade Commission calls into question how ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

The DSU alumnus and businessman focused on values-driven leadership, enrollment strategies and building partnerships during the last public presentation in the university’s search process.

After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...

Two Sigma Investments, a tech-powered hedge fund run by data-loving geniuses, recently upped its bet on pharmaceutical ...

Eli Lilly & Co. said Tuesday it’s cutting ... as there were shortages and a high patient need. Against that background, Lilly is launching 7.5-milligram single-dose vials and 10-milligram ...

Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...